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Summary
Aneuploidy has long been suggested to be causal in
tumor formation. Direct testing of this hypothesis
has been difficult because of the absence of methods
to specifically induce aneuploidy. The chromosome-
associated kinesin motor KIF4 plays multiple roles in
mitosis, and its loss leads to multiple mitotic defects
including aneuploidy [1–5]. Here, we have taken ad-
vantage of the direct formation of aneuploidy in the ab-
sence of KIF4 to determinewhether loss of amolecular
motor andgenerationof aneuploidyduringmitosis can
trigger tumorigenesis. We find that embryonic stem
cells genetically depleted of KIF4 support anchorage-
independent growth and form tumors in nude mice.
In cells lacking KIF4, mitotic spindle checkpoints and
DNA-damage response pathways are activated. Down
regulation or loss of KIF4 is physiologically relevant
because reduced KIF4 levels are present in 35% of hu-
man cancers from several tissues. Our results sup-
port the notion that loss of a molecular motor leads
to tumor formation and that aneuploidy can act as a
primary trigger of tumorigenesis.
Results
We sought to analyze the tumor potential of cells lacking
the motor protein KIF4. To this end, we used a homoge-
nous population of murine KIF4 KO embryonic stem (ES)
cells generated by gene disruption via insertion of b-Geo
near the 50 end of the gene (see the Supplemental Exper-
imental Procedures available with this article online for
details). KIF4 is located on the X chromosome, and
male ES cells with a disrupted KIF4 gene are thus KIF4
null. Absence of KIF4 was confirmed by Western blot
analysis and immunofluorescence microscopy (Figures
S1A and S1B). Loss of KIF4 in murine ES cells leads to
the expected multiple mitotic defects including chromo-
some misalignments, spindle defects, and aberrant cy-
tokinesis (Figure 1A). In addition, a substantial popula-
tion of KIF4 KO mitotic cells formed anaphase bridges
(Figure 1B). Disruption of the KIF4 gene produces pro-
nounced cytokinesis defects, and as a consequence,
a large number of KIF4 KO cells were binucleate or
had multiple nuclei including micronuclei. These defects
were primary in nature and were not due to prolonged
*Correspondence: mazumdam@mail.nih.gov (M.M.); mistelit@mail.
nih.gov (T.M.)culturing of the cell lines in the absence of KIF4, because
RNAi depletion in the parental mouse ES cells for as little
as 16 hr yielded identical phenotypes (Figure 1A; [3]).
SKY analysis of KIF4 KO cells revealed frequent numer-
ical chromosome changes (Figure 1D). More than 70%
of KIF4 KO cells were aneuploid, and chromosome num-
bers varied widely, from as low as 29 chromosomes to
near diploid numbers. In comparison, parental control
cells were invariably diploid. Although no recurrent
chromosomal translocations were observed, nonclonal
rearrangements occurred in 12 out of 30 KIF4 KO karyo-
types (Figure 1D).
KIF4 KO Cells Support Anchorage-Independent
Growth and Tumor Formation
Having established the fact that KIF4 KO cells were
aneuploid, we sought to determine whether they had
tumor potential. When we tested KIF4 KO cells in a stan-
dard soft-agar anchorage-independent growth assay,
they were able to form colonies as efficiently as the
positive control NIH-3T3 cells transformed by HA-Ras
(400 6 38 colonies/104 cells versus 350 6 90 colonies/
104 cells) (Figure 2A). In the negative control, parental
ES cells formed only 131 6 55 colonies/104 cells, and
nontransformed NIH-3T3 cells formed 14 6 2 colonies/
104 cells (Figure 2A; p < 0.001). The somewhat higher ca-
pacity of parental wild-type cells compared to nontrans-
formed fibroblasts to form colonies is consistent with
the established ability of ES cells to form teratomas [6].
To determine whether KIF4 KO cells are able to give
rise to tumors in a more physiological setting, we intro-
duced KIF4 KO cells into nude mice (Figure 2B). Tumors
appeared within six days and increased in size and num-
ber over the next 15 days (Figure 2B). The ability of KIF4
KO cells to form tumors was similar to that of HA-Ras-
transformed NIH-3T3 cells (data not shown). In control
mice injected with parental ES cells, only a few, signifi-
cantly smaller tumors were detected during the same
period (p < 0.001; Figure 2B). Compared to tumor tissue
derived from control cells, tumor tissue derived from
mice injected with KIF4 KO cells showed a significantly
increased proportion of proliferating cells (p = 0.0018;
Figures 2C and 2D), but no significant difference in apo-
ptotic cells was detected (data not shown), suggesting
that tumor formation was due to hyperproliferation of
KIF4 KO cells. We conclude that loss of KIF4 increases
the potential of ES cells for tumor formation.
To determine whether loss of KIF4 was relevant to
human tumors, we probed the NCI-60 tumor cell line
collection for human KIF4 by Western blotting (Fig-
ure 2E). KIF4 was entirely absent or expressed at low
levels in 35% (14/40) of tested tumor samples. No or re-
duced levels of KIF4 was found in tumors from the ovary
(4/6), lung (1/6), breast (1/6), and CNS (1/2), and in renal
tumors (3/4), melanoma (3/4), and leukemia (3/6). No re-
duction of KIF4 was found in colon cancer cell lines (0/7)
(Figure 2E). The variations in KIF4 levels among tumor
samples were specific because comparable levels of
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1560Figure 1. KIF4 Knockout Mouse ES Cells Have Mitotic Defects and Aberrant Chromosome Structure and Are Aneuploid
(A) Mitotic defects in all phases of mitosis. Microtubules (red); DNA (blue). The scale bar represents 5 mm.
(B) Anaphase bridge formation in KIF4 KO cells. DAPI (white). The scale bar represents 5 mm.
(C) Chromosome hypercondensation and aneuploidy in KIF4 KO cells. Metaphase spreads of parental control and KIF4 KO cells reveal hyper-
condensation and frequent aneuploidy upon loss of KIF4. The number of chromosomes in the spread is indicated.
(D) Spectral karyotyping of KIF4 KO cells. A representative karyotype from a SKY analysis of KIF4 KO ES cells displaying the pseudocolored
image and the corresponding inverted DAPI image for each chromosome. The numbers at the bottom of each box represent the chromosome
number. A KIF4 KO cell with a pseudodiploid karyotype lacking chromosome X and one homolog of chromosome 12 (white arrows). The arrow
in box 1 indicates a complex Robertsonian translocation involving chromosomes 1 and 16, respectively, to give a complex karyotype of 38,2X,
Y, Rb[1; T(16;1)], 212.the protein were detected in tissues from healthy indi-
viduals and in several randomly selected cell lines and
human tissue extracts (Figure S2).
KIF4 Disruption in Mouse ES Cells Activates
Spindle Checkpoints and Causes Centrosome
Supernumerary
Next, we sought to explore the mechanism by which
loss of KIF4 gives rise to tumors. Because KIF4 KO cells
were still able to proliferate despite the presence of sig-
nificant chromosomal defects and aneuploidy, we hy-
pothesized that cell-cycle checkpoints were overridden
in KIF4 KO cells. Indeed, KIF4 KO cells showed activa-
tion of spindle-assembly checkpoints (Figures 3A and
3B). The checkpoint sensor protein Mad2 was, in addi-
tion to its localization to centrosomes, associated with
misaligned chromosomes in KIF4 KO cells and partially
colocalized in these cells with the kinetochore marker
CREST (Figure 3A, inset). In contrast, Mad2 in control
cells was typically found only at the spindle poles and
was absent from kinetochores (Figure 3B). Similarly,
the spindle-checkpoint protein BubR1 was associated
with hypercondensed chromosomes in KIF4 KO cells
but was absent from kinetochores in control cells
(Figure 3B, inset). Because KIF4 in normal cells is pres-
ent all along the length of the chromosome arms, it is
possible that loss of KIF4 and the observed hypercon-
densation of mitotic chromosomes affects spindle-microtubule attachment sites, tensions, or both, and
thus leads to activation of the mitotic spindle check-
points in KIF4 KO cells [7].
Centrosome amplification and structural abnormali-
ties of centrosomes are commonly found in tumor cells
[8, 9]. Although it is not clear whether centrosomal de-
fects are a cause or consequence of cancerous transfor-
mation, formation of supernumerary centrosomes can
lead to mitotic abnormalities and multipolar spindles
[10, 11]. Because multipolar spindles are often found in
KIF4 KO cells, we determined the status of centrosomes
in these cells. We found that 34%6 3% of KIF4 KO cells
have numerical aberrations of centrosomes compared
to 0.5% 6 0.05% of control parental cells (Figures 3C
and 3D). KIF4 KO cells often contained between three
and six centrosomes as opposed to the two normally
found in mitotic control ES cells (p < 0.0001; Figures
3C and 3D). Centrosome supernumerary may arise
from centrosome fragmentation or polyploidization, al-
though the rate of aneuploidy was significantly higher
(70%) than the percentage of cells containing supernu-
merary centrosomes (34%). In addition, centrosomes
in KIF4 KO cells were often structurally abnormal, show-
ing irregular shapes and coalescence of multiple centro-
somes (Figures 3C and 3D). Therefore, consistent with
the observed aneuploidy and their ability to form tu-
mors, KIF4-depleted cells exhibit centrosome abnor-
malities.
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1561Figure 2. KIF4 KO ES Cells Have the Potential to Form Tumors
(A) Soft-agar colony-formation assay with NIH 3T3 cells (negative control), HA-Ras-transformed cells (positive control), parental ES cells (neg-
ative control), and the KIF4 KO ES cells in triplicates. Anchorage-independent growth was measured by quantification of the number of colonies
formed per 104 cells plated. Values represent averages 6SD from three experiments with triplicate plates.
(B) Tumor formation by control ES and KIF4 KO ES cells in nude mice. Control ES and KIF4 KO ES cells (5 3 106 cells per site) were injected
subcutaneously into two flank sites of each nude mouse (five mice per group). Mice were examined for tumor formation, and tumor size was
measured at the indicated time. Tumor volume is presented as the mean volume (mm3) 6SD of tumors from ten injection sites per group.
(C) Proliferation of tumor cells. Anti-BrdU immunostaining of tumors of the indicated genotypes in nude mice. Magnification is 3 400.
(D) Proliferation rates in control ES and KIF4 KO ES tumors. We quantified tumor cell proliferation by counting BrdU-labeled cells on histological
sections. Results are the mean 6 SEM for a minimum of five tumors of each genotype.
(E) KIF4 protein-expression profiling in human cancer cell lines. The NCI-60 set of cancer cell lines was tested with Western blots for KIF4 protein.
Fourteen of forty cell lines showed lower KIF4 expression or complete loss of KIF4 expression. Actin or core histone H3 was used as loading
controls.Activation of DNA-Damage Checkpoints
upon Loss of KIF4
A recently discovered fundamental hallmark of cells with
tumor potential and early tumor cells is the activation of
DNA-damage response pathways [12, 13]. It has been
suggested that activation of these pathways serves as
a surveillance mechanism to eliminate cells with tumor-
igenic potential and that defects in these pathways al-
low escape of tumorigenic cells [12, 13]. Thus, we asked
whether loss of KIF4 results in activation of DNA-damage
response pathways (Figure 4). Consistent with their ac-
tivation, phosphorylated histone gH2AX and activatedATM kinase, two early DNA damage sensors, acculu-
mated extensively in mitotic chromosomes in KIF4 KO
cells (Figures 4A and 4B). In contrast, significantly lower
but detectable levels of gH2AX and no activated ATM ki-
nase were found on chromosomes of control cells (Fig-
ures 4A and 4B). We demonstrated the general activa-
tion of DNA-damage response pathways by Western
blotting of whole-cell extracts. KIF4 KO cells showed
high levels of phosphorylated gH2AX and the early
DNA-damage repair component NBS1 (Figures 4A and
4C). Both major DNA-damage response pathways act-
ing via the ATM and the ATR kinases were activated in
Current Biology
1562Figure 3. Centrosome Abberations and Acti-
vation of Spindle Checkpoints in KIF4 KO
Cells
(A) Activation of mitotic checkpoints in KIF4
KO cells. MAD2 (red) in control cells, localizes
at centrosomes but is absent from kineto-
chores identified by anti-CREST antibody
(green). In KIF4 KO cells, CREST and MAD2
partially colocalize (inset). Scale bars repre-
sent 5 mm.
(B) BubR1 is found on kinetochores of KIF4
KO cells but not in control cells (inset). Scale
bars represent 5 mm.
(C) Confocal-microscopy analysis of fixed
parental E14 and KIF4 KO cells at various
stages of mitosis. Multiple centrosomes or
coalescence of two or more centrosomes
are frequently observed in KIF4 KO ES cells.
Centrosomal marker protein g-tubulin is in
red, and DNA is in blue. Scale bars represent
5 mm.
(D) Quantitation of centrosomal numerical
abnormalities. A minimum of 100 cells were
counted from ten randomly chosen fields
from each of three different samples. The
values represent averages 6 SD.KIF4 KO cells as indicated by increased phosphorylation
of ATM at S1981 and its downstream kinase Chk1 at
S345 and by phosphorylation of Chk2 at T68 and its
downstream target p53 on S15 in KIF4 KO cells (Figures
4B and 4C). Consistent with the view that activation of
DNA damage pathways is a hallmark of early, but not
late, tumor cells was the fact that no significant activa-
tion of most markers, with the exception of Chk1 and
Chk2, was observed in tumors derived from the nude
mice (Figure 4C).
To exclude the possibility that activation of DNA-dam-
age response pathways in KIF4 KO cells was a second-
ary effect, we examined the status of the two DNA-dam-
age response pathways in parental ES cells from which
KIF4 had been depleted by RNAi for 24 hr (Figures 4A–
4C). This time period is sufficient to reduce the cellular
level of KIF4 by more than 80% but eliminates the pos-
sibility of artifactual long-term effects ([3]; data not
shown). As we observed in KIF4 KO cells, g-H2AX and
phosphorylated ATM accumulated rapidly on mitotic
chromosomes of KIF4-depleted cells but were absent
in cells treated with control RNAi (Figures 4A and 4B).
Western blotting confirmed the immediate activation of
DNA-damage response pathways upon loss of KIF4
(Figure 4C). gH2AX, NBS1 ATM, Chk1, Chk2, and p53
were all activated as indicated by their increased phos-
phorylation in RNAi-treated cells compared to control
cells (Figure 4C). We conclude that activation of DNA-
damage response pathways is an immediate response
of cells to loss of KIF4.Discussion
We demonstrated here that loss of a molecular motor
protein can lead to tumor formation. A physiological
role for KIF4 in tumor formation is strongly suggested
by its absence in 35% of randomly selected tumor cell
lines. Furthermore, KIF4 has been found to be misex-
pressed in premalignant trophoblasts [14], and HKIF4A
has recently been identified by microarray analysis as
one of the most dramatically down-regulated genes in
tumors with metastatic potential [15]. The observed ac-
tivation of DNA-damage response pathways upon loss
of KIF4 in cells is consistent with the recent realization
that activation of these pathways is an early hallmark
of cells with tumor potential [12, 13]. These results ex-
tend earlier observations in cell culture showing that
loss of other mitotic motors can lead to aneuploidy
[16, 17]. Our observation of tumor formation via loss of
a molecular motor is a novel concept in the fields of mo-
lecular motors and tumor biology.
Because the primary effects of loss of KIF4 are mitosis
defects leading to aneuploidy, our results support the
notion that aneuploidy can trigger tumorigenesis [18,
19]. Although the mechanisms by which aneuploidy
causes tumors is unclear, likely candidates are stochas-
tic reduction of tumor-suppressor gene dosage and on-
cogene amplification due to changes in copy number.
Although our observations suggest that aneuploidy can
act as the first step in tumor formation, they do not
show that it is in itself sufficient for the formation of
KIF4 in Aneuploidy and Tumor Formation
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cations might be a consequence of KIF4 deletion and
might be instrumental in the early process of tumor
formation [9, 20]. Similarly, we also can not rule out the
presence of other secondary events, such as mutations
in tumor suppressors, upon loss of KIF4. However,
these would be downstream events facilitated by the
Figure 4. DNA-Damage Pathways Are Activated in KIF4 KO ES Cells
(A and B) Confocal immunofluorescence microscopy images of
control, KIF4 KO ES, and parental ES cells depleted of KIF4 by
RNAi for 24 hr. Cells are stained for g-H2AX or pS1981-ATM (green)
and DNA (blue). KIF4 KO and KIF4 RNAi ES cells showed both g-
H2AX and pS-ATM foci, indicating activation of the DNA-damage
pathway in these cells. Scale bars represent 5 mm.
(C) Immunoblot analysis of total cell extracts from control cells, KIF4
KO ES cells, tumors derived from nude mice injected with control
and KIF4 KO ES cells, and parental ES cells depleted of KIF4 for
24 hr. Actin was used as the loading control.aneuploid nature of KIF4 KO cells. Finally, it remains to
be determined how faithfully the hyperproliferative
tumors in nude mice represent human tumors.
The mechanism for KIF4-loss-mediated tumorigene-
sis is likely to be directly linked to its role in mitosis.
Loss of KIF4 leads to numerous mitotic defects, includ-
ing chromosome hypercondensation, aberrant spindle
formation, anaphase bridges, defective cytokinesis,
and aneuploidy [3–5]. Any of these defects may activate
mitotic checkpoints and DNA-damage response path-
ways. Although many cells with defective mitoses will
be eliminated by apoptosis or subsequent cell-cycle
arrest, some KIF4 KO cells with genomic defects may
escape these checkpoints, allowing them to proliferate
and to form tumors [12, 21]. This scenario is consistent
with previous observations indicating that loss of human
KIF4A does not lead to a complete block in cell-cycle
progression but merely to a slowed progression through
mitosis [3]. One might then predict that any defects that
lead to slippage of cells with genomic defects through
mitosis can give rise to tumor cells. [22, 23]. Indeed, het-
erozygotic loss of Mad2 or BubR1, which weakens but
does not completely eliminate mitotic checkpoints,
results in aneuploidy, and in some cases increases
tumor formation [24–30]. These considerations strongly
support the emerging view that slippage of aneuploid
cells through mitosis is a potent mechanism of tumor
formation [22].
Supplemental Data
Supplemental Experimental Procedures and two figures are avail-
able with this article online at: http://www.current-biology.com/
cgi/content/full/16/15/1559/DC1/.
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